ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,375, issued on Feb. 10, was assigned to The Board of Trustees of the Leland Junior University (Stanford, Calif.) and Atomwise Inc. (San Francisco).

"Small molecule therapeutic for parkinson's disease paired with a biomarker of therapeutic activity" was invented by Xinnan Wang (Redwood City, Calif.), Chung-Han Hsieh (Palo Alto, Calif.), Li Li (Palo Alto, Calif.) and Kong Nguyen (Moraga, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions are provided for the treatment of Parkinson's Disease. Aspects of the methods include administering Miro1 reducer. Also provided are reagents and kits for practicing the subject methods. In...